» Authors » Ginger Carls

Ginger Carls

Explore the profile of Ginger Carls including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 151
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jennum P, Kjellberg J, Carls G, Ibsen R, Mettam S
Sleep Med . 2024 Apr; 118:93-100. PMID: 38657350
Objective: Excessive daytime sleepiness (EDS) persists in some patients with obstructive sleep apnea (OSA) despite continuous positive airway pressure (CPAP) treatment. This study characterized response to CPAP and factors associated...
2.
Pocobelli G, Akosile M, Hansen R, Eavey J, Wellman R, Johnson R, et al.
Sleep Med . 2021 Aug; 85:196-203. PMID: 34348205
Objective: To evaluate the association between obstructive sleep apnea (OSA) and risk of motor vehicle accident (MVA). Methods: We conducted a cohort study at Kaiser Permanente Washington using electronic health...
3.
Ohayon M, Thorpy M, Carls G, Black J, Cisternas M, Pasta D, et al.
Sleep Med . 2021 Jul; 84:405-414. PMID: 34304148
Objective/background: The real-world experience of people with narcolepsy is not well understood. Patients/methods: The Nexus Narcolepsy Registry (NCT02769780) is a longitudinal, web-based patient registry of self-reported data from adults with...
4.
Thorpy M, Ohayon M, Carls G, Black J, Pasta D, Hyman D, et al.
Sleep Med . 2021 Jul; 84:380-388. PMID: 34247126
Background: The aim of this study was to evaluate the impact of different therapy regimens, including sodium oxybate (SXB)-containing regimens, on patient-reported outcomes (PROs) in people with narcolepsy. Methods: Online...
5.
Carls G, Reddy S, Broder M, Tieu R, Villa K, Profant J, et al.
Sleep Med . 2019 Dec; 66:110-118. PMID: 31841742
Background: This study analyzed a privately insured pediatric population with and without narcolepsy to determine the impact of pediatric narcolepsy on comorbidities, health care utilization, and cost. Additional analyses compared...
6.
Henry R, Rosenstock J, McCarthy J, Carls G, Alessi T, Yee J, et al.
Diabetes Obes Metab . 2017 Oct; 20(3):638-645. PMID: 29053202
Aims: To evaluate treatment satisfaction in patients with type 2 diabetes (T2D) not adequately controlled by metformin, randomized to ITCA 650 (continuous exenatide in osmotic mini-pump) vs twice-daily exenatide injections...
7.
Carls G, Huynh J, Tuttle E, Yee J, Edelman S
Diabetes Ther . 2017 Jun; 8(4):863-873. PMID: 28646411
Introduction: Previous research has found that the percentage of US adults with diabetes achieving a glycated hemoglobin (HbA1c) target of <7.0% with currently available treatments has been fairly constant from...
8.
Chawla A, Carls G, Deng E, Tuttle E
Pharmacoeconomics . 2015 Jun; 33(7):749-63. PMID: 26054325
Background: Following withdrawals, failures, and significant litigation settlements, drug product launches in the anti-obesity category slowed despite a large and growing unmet need. Litigation concerns, a more risk-averse regulatory policy,...
9.
Carls G, Li T, Panopalis P, Wang S, Mell A, Gibson T, et al.
J Occup Environ Med . 2009 Jan; 51(1):66-79. PMID: 19136875
Objectives: To estimate the medical- and productivity-related cost burden of systemic lupus erythematosus (SLE) and SLE with nephritis in an employee population. Methods: Using administrative data, annual costs were calculated...